SEER*Rx Interactive Antineoplastic Drugs Database

A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.

Name	Category	Primary Site	Code?
131I-MIBG	Radiation		See Remarks
5-Aza-2'Deoxy-cytidine	Chemotherapy	CML	Yes
ABT 888	Chemotherapy	Ovary	Yes
AMG 531	Ancillary Agent		No
Abemaciclib	Chemotherapy	Breast	Yes
Abiraterone acetate	Hormones and hormonal mechanisms	Prostate	Yes
Abiraterone acetate/niraparib	Chemotherapy	Prostate	See Remarks
Acalabrutinib	Chemotherapy		Yes
Acetaminophen	Ancillary Agent		No
Acetazolamide	Ancillary Agent		No
Acetylcysteine	Ancillary Agent	AIDS, Opportunistic infection	No
Acitretin	Differentiation inducing agent		No
Acyclovir	Ancillary Agent		No
Acyclovir Sodium	AIDS drug		No
Ado-trastuzumab emtansine	Biologic therapy (BRM, immunotherapy)	Metastatic HER-2 breast cancer	Yes
Adrenocorticotropic hormone	Hormones and hormonal mechanisms		See Remarks
Adstiladrin	Biologic therapy (BRM, immunotherapy)	bladder	Yes
Albendazole	AIDS drug		No
Albuterol Sulfate	Ancillary Agent		No
Alectinib	Chemotherapy	Lung	Yes
Alemtuzumab	Biologic therapy (BRM, immunotherapy)	Leukemia, lymphoma	Yes
Alendronate Sodium	Ancillary Agent		No
Alitretinoin	Differentiation inducing agent	Kaposi sarcoma	No
Allopurinol	Ancillary Agent		No
Altretamine	Chemotherapy	Ovarian cancer	Yes

Name	Primary Site
7+3	AML
AAVD	Hodgkin's Lymphoma
ABCD
ABCM
ABCP	Lung
ABD
ABDIC
ABVD	Hodgkin lymphoma
AC	Breast
AC-T	Breast
ACOAP
ACOPP
ACT-FU-Cy
ACVBP
AD
ADE	AML
ADM
ADOC
AIM	Sarcoma
ALOMAD
APO regimen
ASHAP
ASHAP/M-BACOS
ATRA (263)
AVD	Lymphoma

Glossary